Lenvatinib plus pembrolizumab combination shows promise in advanced kidney cancer
Interim results from Study 111, a phase Ib/II clinical trial [...]
Interim results from Study 111, a phase Ib/II clinical trial [...]
NICE has issued draft guidance this week turning down two [...]
The following article provides a comprehensive summary of the changing [...]
In recent years, drugs that target the vascular endothelial growth [...]
This week saw the initiation of a global phase III [...]
The European Commission has approved Kisplyx (lenvatinib) for the treatment [...]
Cabozantinib (Cabometyx, Ipsen Pharma) and lenvatinib (Kisplyx, Eisai Europe Ltd) [...]
Data presented at the American Society of Clinical Oncology (ASCO) annual [...]
The FDA has approved the combination of lenvatinib (Lenvima) and [...]